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after Hematopoietic Stem Cell Transplantation
for Childhood Malignant and Nonmalignant Diseases
Does Not Show Significant Impairment Compared
with Healthy Controls: A Case-Matched Study
Cornelio Uderzo,1 Paola Corti,1 Marco Pappalettera,2 Valentina Baldini,2 Giovanna Lucchini,1
Dario Meani,1 Attilio Rovelli1Patients undergoing hematopoietic stem cell transplantation (HSCT)may experience physical and psycholog-
ical deterioration that impairs their life satisfaction (LS). This study focused on LS in long-term survivors at 10
or more years after HSCT. Fifty-five patients (39 males, median age 25 years) undergoing allogeneic HSCT for
childhood malignant (n5 52) or nonmalignant diseases (n5 3) were enrolled. A control group of 98 young
adults (59 males, median age 24 years) was considered. A questionnaire with a modified Satisfaction Life
Domain Scale was administered. We assessed such domains as education, employment, leisure time, social
relationships, and perception of physical status with a 30-item questionnaire. To investigate the association
between the domains and the probability of diminished LS, we performed a logistical procedure using the
maximum likelihood method. Predictive factors of LS were adjusted for sociodemographic variables.
In the multivariate analysis, the participant’s level of LS was not significantly correlated with sociodemo-
graphic factors or with HSCT status. The same analysis showed a slight trend in favor of the control group
(P 5 .06) for body perception. Our data suggest that the patients who undergo HSCT in childhood have
no significant difference in long-term LS compared with healthy controls.
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Survivor, ResilienceINTRODUCTION
The majority of previous clinical trials concerning
childhood malignant and nonmalignant diseases have
shown great improvement in short-term and long-
term outcomes after chemotherapy or hematopoietic
stem cell transplantation (HSCT) in recent years. In
particular, studies conducted in the last decade have in-1Pediatric Department and Bone Marrow Transplant
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oi.org/10.1016/j.bbmt.2012.06.015dicated that total cure can be achieved in 60%-90% of
pediatric patients with acute lymphoblastic leukemia
or acute or chronic nonlymphoblastic leukemia [1-4].
Thus, there has been a strong interest in national and
international studies on late effects after HSCT [5,6]
and, more recently, on cognitive and behavioral out-
comes [7]. HSCT recipients are an important group
to consider for late physical and psychological deteri-
oration that impairs quality of life (QOL) or life satis-
faction (LS). LS is a subjective measure of satisfaction
related to physical, cognitive, emotional, social func-
tioning, and well-being [7,8].
Although some previous QOL and LS studies
have been conducted with adult HSCT recipients
[8,9-16], few well-documented reports have focused
on these issues in childhood HSCT [17-19]. The prin-
cipal purpose of the present pilot study was to evaluate
health status and LS in young adult HSCT survivors to
assess whether they are participating normally in social,
family, educational, and employment contexts. A com-
parison with a healthy control group was used for clin-
ical interpretation of the results and to identify specific1759
Table 1. Questionnaire for LS Self-Assessment of Patients
Undergoing HSCT
1760 Biol Blood Marrow Transplant 18:1759-1770, 2012C. Uderzo et al.risk factors that could impair the HSCT recipients’
long-term LS.School domain
1) Which level of education (elementary, secondary, university)?
2) Any school performance and /or education failure? (please specify yes/
no and how many times)
3) Which kind of difficulties? please specify whether difficulties have been
solved or not
4) Which learning efficiency? (*)
5) Which attendance grade? (*)
6) Any pleasure in obtaining efficient education? (*)
7) Any discomfort or not with schoolmates? (*)
8) Which relationship with teachers? (*)
9) Any causes of discomfort with schoolmates or teachers?
10) Which future projects do you have?
Job domain
11) Which kind of job and for how long?
12) Is the actual job in line with your own aspirations? (*)
13) Do you like your job? (*)
14) Are you comfortable or not with your colleagues? (*)
15) Are you comfortable with your superiors? (*)
16) Did you change frequently your job and if yes how many times and why
17) Do you have future projects?
Leisure time domain
18) Which kind of sport, when and how many times (†)
19) Do you like Music? (indicate any kind of instrument you use or prefer †)
20) Which Hobbies do you like and for how long? (†)
21) Any other activities?(†)
Relationship domain
22) With relatives and your own family
23) With your own boy or girlfriend, if any
24) Marriage: what about it, since when, and are you satisfied
25) Any life difficulties after HSCT? (specify if difficulties have been solved or
not)
26) Did you undergo psychosocial support (if yes, for how long)
27) Any psychologic impact of previous disease or HSCTon normal
relationship?
27) Are you satisfied with your body perception including sexuality and
fertility?(*)
28) Are there any physical activities that are not allowed to you and if yeswhy
General comments
29) Are you satisfied for the assistance received in your HSCT center (*)
30) Any other comments?
*Score 1-4 (insufficient, sufficient, good, very good).
†Score 1-4 (once, twice a week, a fortnight, never).PATIENTS AND METHODS
All patients diagnosed with a malignant or nonma-
lignant disease and treated by allogeneic HSCT in our
center between 1985 and 1998 were contacted by mail
or e-mail to elicit their participation in the study. The
recruitment period was limited to 2 years.
Patients were eligible for enrollment who were
disease-free after HSCTperformed at least 10 years be-
fore the start of this study. Eligibility criteria also in-
cluded any stem cell source or donor, as well as patient
or parent/guardian written consent. Adolescents or
young adults who met all of the inclusion criteria were
approached to participate in the study at a scheduled
checkup. In our center, a checkup is generally scheduled
every 2 years for patients who survive for more than
10 years afterHSCT.Medical and demographic param-
eters extracted from medical records included age, sex,
type of HSCT, type of stem cell source and donor, con-
ditioning regimen, and post-HSCT complications, in-
cluding graft-versus-host disease (GVHD) and late
effects. Patients were given a written questionnaire after
signing an informed consent that was explained by the
senior physician providing care at the time of HSCT.
Health and LS were self-assessed using a question-
naire basedon thepatient’s level of satisfactionusing the
Satisfaction with Life Domains Scale (SLDS-BMT)
[12] adapted by our center and approved by our Institu-
tional Ethics Committee. The questionnaire covered 5
core domains identified as likely themost important for
adolescents and young adult HSCT survivors.
The domains were as follows: 1, schooling (level of
education, school performance, relationship with
teachers and classmates, future plans); 2, employment
(relationship with colleagues, future projects); 3, lei-
sure time and physical functioning (sport activities,
hobbies, other); 4, relationships and social functioning
(family relationships, friendships, girlfriend/boyfriend
interaction, social participation); and 5, body image
(perception of subjects’ physical status, including sex-
uality and long-term post-HSCT sequelae). Details
of the questionnaire are presented in Table 1.
The domains contained 2-10 items each, for a total
of 29 questions. Answers were evaluated by a single psy-
chologist at our center. Somequestionswere formulated
with answers on a 4-point scale: insufficient, sufficient,
good, or very good. Higher scores ($3) indicated
greater LS. A series of open-ended answers at the end
of each domain were included. The patient was asked
to provide a final comment concerning satisfaction
with the helpfulness of our HSCT center’s personnel
in terms of psychological and healthcare support.
Healthy young adults visiting our hospital for
blood donation at the same time as the HSCT recipi-ents were visiting for checkups were chosen as the age-
and sex-matched control group. The individuals in this
control group were asked to provide informed consent.
The questionnaire was administered to the control
group in the same manner as in the HSCT recipients.
Statistical Analysis
We set up a case-control study (ratio 1:2) to assess
LS. This study was based on the analysis of a 30-item
questionnaire, with 10 of 30 items set in a quantitative
ordinal scale (ie, teacher, family relationships, and so
on) contributing to the overall score, that is, the depen-
dent variable in our statisticalmodel. The other 20 items
were on a nominal scale (qualitative, ie, sex, education
level, hobbies) and did not contribute to the overall
score, but were considered independent variables in the
statistical model.
We evaluated the probability of LS through a mul-
tivariate analysis according to the logistical procedure
(SAS version 8; SAS Institute, Cary, NC) using the
method of maximum likelihood. Logistic regression
Table 2. Characteristics of Patients and Controls
Cases Controls
Enrolled subjects, n 56 98
Evaluable subjects, n 55 98
Sex, M/F, n 39/17 59/39
Biol Blood Marrow Transplant 18:1759-1770, 2012 1761SCT in Childhood and Life Satisfactionallowed us to investigate the relationship between
a categorical outcome (satisfaction, yes/no) and a set
of variables (prognostic factors). Our logistical proce-
dure was similar to other regression procedures, but
with a dichotomous outcome as a dependent variable;
binary responses were LS (yes/no). LS included a lim-
ited number of domains: work/school problems, fam-
ily relationships, leisure time, and body perception.
Ratings were made on a 4-point scale for each domain,
and the items were then summed to give an overall LS
score. The overall score was calculated by subject, not
by items (ie, variables), so each subject with a score
above or below the 75th percentile among all subjects
was classified as ‘‘satisfied’’ or ‘‘not satisfied’’, respec-
tively [20]. We dichotomized the dependent variable
(overall score) because the assumptions for the model
with the score in a continuous numeric scale (linear re-
gression model) were not satisfied. This explains our
choice to use a logistical model.
We used the stepwise effect selection method to
identify the prognostic factors for LS. Effects were en-
tered or removed from themodel according to a signif-
icance level of 0.30 for a variable to be both placed into
and remain in themodel and a significance level of 0.30
for a variable to stay in the model. The stepwise selec-
tion process was terminated if no further effect could
be added to the model, or if the effect that had just en-
tered the model was the only one removed in the sub-
sequent backward elimination [20].
The relationship between the independent and de-
pendent variables was expressed in terms of odds ratio
with 95% confidence interval, computed as the expo-
nential of the parameter estimate. The predictive ability
of the model was assessed used the Somer D index,
which is the difference between the percentage of con-
cordant and discordant pairs of predicted probability
and observed responses, divided by 100. Prognostic fac-
tors, such as age (as a continuous variable), sex, HSCT,
case versus control, level of education, work, free time,
and life projects,were evaluated todefine theprobability
of LS of all the subjects studied. A c2 test statistic was
used to assess the association between transplantation
status (transplanted–controls) and domains. An un-
paired 2-sample t-testwas used for continuous variables.Malignant disease, ALL/CML/AML/
NHL, n
52 (31/7/11/2)
Nonmalignant disease, MDS/SAA, n 3 (2/1)
Age at diagnosis, years, median (range) 5.2 (0.8-14.9)
Age at HSCT, years, median (range) 9.0 (1.1-17.9)
HSCT type, FD/URD/CB, n 51/3/1
Conditioning regimen, TBI/no TBI, n 36/19
Acute GVHD, grade I-II/III-IV, n 41/101
Chronic GVHD, limited/extended, n 1/2
Time after HSCT, years, median (range) 12.2 (10.2-17.1)
Age at study, years, median (range) 25 (18-40) 24.5 (18.1-38.8)
ALL indicates acute lymphoblastic leukemia; AML, acute myelogeneous
leukemia; CB, cord blood; CML, chronic myelogeneous leukemia; FD,
family donor; MDS, myelodysplastic syndrome; NHL, non-Hodgkin lym-
phoma; SAA, severe aplastic anemia; TBI, total body irradiation; URD,
unrelated donor.RESULTS
Of 160 recipients of allogeneic HSCT performed
between 1985 and 1998, 116 young adults were alive,
without evidence of disease and eligible for this study.
Fifty-six of the 116 eligible patients had a checkup at
our HSCT center between June 2008 and June 2010.
Only 1 of these 56 patients refused to participate in
the study. Completion of the questionnaire took an
average of 18 minutes for the HSCT recipients and
21 minutes for the controls. Characteristics of the pa-
tient and control groups are summarized in Table 2.Out of 56 enrolled patients (39males), 53 had ama-
lignant disease and 3 had a nonmalignant disease. The
median age was 5.2 years (range, 0.8-14.9 years) at di-
agnosis, 9.0 years (range, 1.1-17.9 years) at HSCT, and
25 years (range, 18-40 years) at the time of the study.
Themedian follow-up from the time ofHSCTwas
12.2 years (range, 10.2-17.1 years). Of the 55 patients
assessed, 51 had undergone related donor HSCT, 3
had undergone unrelated marrow donor HSCT, and
1 had undergone unrelated cord blood donor HSCT.
Thirty-six of the 55 patients had received a pretrans-
plantation conditioning regimen including fractioned
total body irradiation.
AcuteGVHDoccurred in41patients (10withgrade
III andover), and limitedchronicGVHDoccurred in11
patients. Two 2 patients experienced extensive chronic
GVHD resembling a diffuse sclerodermic pattern. All
the patients were off GVHD treatment and GVHD-
free throughout the study period.
Late effects occurring afterHSCTwere detected in
42 of the 55 patients. Fifteen of these 42 patients pre-
sented with late effects in more than one organ. These
late effects included hypergonadotropic hypogonadism
(n5 29), actinic amenorrhea (n5 6), subclinical hypo-
thyroidism (n 5 15), non–insulin-dependent diabetes
mellitus (n5 5), cataracts (n529), secondarymalignan-
cies (follicular thyroid carcinoma, n5 2), mild pulmo-
nary restrictive syndrome (n 5 16), mild pulmonary
obstructive syndrome (n 5 3), arterial hypertension
(n5 4), severe cardiomyopathy (n5 1), severe osteopo-
rosis (n5 1), hepatic nodular hypertrophy (n5 2), and
chronic hepatitisCvirus infection (n5 6).Hormone re-
placement therapy was provided whenever needed.
In our univariate analysis of factors associated with
LS (Figure 1), the only significant difference between
the patient and control groups was in educational level.
At the timeof the study, 79%of thepatientswereattend-
ing secondary school compared with 54% of controls
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Figure 1. Comparison of domains by univariate analysis.
1762 Biol Blood Marrow Transplant 18:1759-1770, 2012C. Uderzo et al.(P\ .0001). Only 8 of the 55 patients refused to attend
secondary school, and 3 of those 8 were unemployed.
Twelve patients (21%) graduated, compared with 44
controls (45%). Two patients graduated from a univer-
sity with a degree in engineering, 2 with a degree in fine
arts, 3 with a law degree, 3 with a degree inmodern arts,
and 2 with a degree in media/language. Thirteen
patients were still enrolled at a university, whereas the
majority of the controls had graduated. Roughly 30%
of the controls who graduated chose a scientific major
course, and 70% chose a nonscientific course.
Slightly more patients than controls (44% versus
33%) had some problems keeping a job, but the differ-
ence was not statistically significant. Good and/or very
good family relationships were recorded in the patient
group (P 5 .003). No major differences were found
between the 2 groups in terms of leisure time (sports
or hobbies). Few members of either group were mar-
ried, likely owing to the low median age of the partic-
ipants. The results showed no differences in how
sexuality was perceived between the 2 groups.
Multivariate analysis showed that the level of LS
was not significantly correlatedwith sociodemographic
factors (eg, sex, age, education, relationships) orHSCT
status. A mild trend in favor of the control group was
seen in the subjects’ body perception factor scores
(odds ratio, 1.894; 95% confidence interval, 0.968-
3.705; P5 .06). The Somer D index was 0.64 (percent
concordant, 54.0%; percent discordant, 10.0%).DISCUSSION
Theaimof this studywas to evaluatehealth andLS in
young adults at 10 ormore years afterHSCTperformed
in childhood for malignant or nonmalignant disease.
The median follow-up was 12.2 years post-HSCT.
Some limitations of this study should be taken into
account, including the relatively small number of pa-
tients, the slightly inadequate comparisonwith controls,
and unavailability of sociodemographic background in-
formation at the time of questionnaire administration.Unfortunately, population norms are not readily avail-
able and, when available, are not always culturally ap-
propriate [19]. Nonetheless, our data indicate that
patients who underwent HSCT in childhood have no
significant difference in LS compared with healthy con-
trols once they reach adolescence or young adulthood.
Educational level constituted the only significant differ-
ence in the univariate analysis, and this was related
mainly to the low number of patients still in secondary
school or at a university at the time of this study. This
was a reasonable finding, given that some of the patients
had delayed their education because of their childhood
illness. In contrast, themajority of controls hadobtained
a secondary schooldiplomaorhadgraduated fromauni-
versity by the time of the interview.
The 2 groups demonstrated no significant differ-
ence in terms of school problems. With regard em-
ployment and future planning, the patient group
expressed a relatively (but not significantly) greater in-
terest in looking for employment. In particular, 2 pa-
tients were seeking a specific job, such as managing
a pub or a farm, and 10 other patients were strongly de-
termined to find a job and start a family. In contrast,
the majority of the control group expressed more cau-
tion about future projects, preferring to attend a school
or university instead of looking for a job.
The 2 groups dedicated an almost equal amount of
time to sports (in particular, physical activities such as
body building).Noparticular between-groupdifference
was seen in terms of hobbies. Interestingly, some of the
HSCT survivors were disposed to original leisure time
activities, such asmusic, painting, ormodel aircraft con-
struction.
Previous studies have found that a proportion of
childhood cancer survivors experience acceptable
physical health and exhibit good psychological and so-
cial behavior with no difference in terms of depression
or self-esteem compared with normal matched con-
trols [21,22]. Difficulties in evaluating LS or QOL in
these previous studies were related to the means of val-
idation, with minimal burden on patients and staff or
Biol Blood Marrow Transplant 18:1759-1770, 2012 1763SCT in Childhood and Life Satisfactionhaving sufficient capacity to follow patients for ex-
tended periods. Similar findings seem to emerge for pa-
tients cured after HSCT, but previous studies have
detected a possible bias, related mainly to differences
in subject age, number of subjects analyzed, type of
transplantation, observation period, type of control
[19,23], and difficulty reaching consensus on which
LS measures should be used [24-26].
A recent review underscored that, notwithstanding
the need for more standardized broad measures of
QOL and LS in the healthy population and survivors
of childhood cancer, general measures might have the
advantage of applicability [7]. We chose this strategy,
which is probably less sensitive than a more complex
approach, such as the subscales that take multi-item
measures into consideration. In addition, a subjective
measurement approach, such as the use of a question-
naire, can provide a better fit with a client autonomy
model in which the client is viewed as the expert with
respect to his or her own life [27].
It is interesting to note that the well-known post-
HSCT complications [28,29] had no significant nega-
tive impact on the psychosocial outcome of our patients
comparedwith controls. This finding was recently con-
firmed in a studyof adultHSCTsurvivors [30], contrary
to previous reports [7,11].
Our results demonstrate that themajority ofHSCT
survivors have great appreciation for life, family, and
friends. Even the center effect, including strong psycho-
logical support fromHSCT staff, was relevant to recov-
ery from the negative impact of the transplantation
procedures, as evidenced by the patient comments.
These findings are in keeping with longitudinal studies
that support anearlydecrease inQOLimmediately after
allogeneic HSCT [25,30,31], but a consistent recovery
to baseline levels thereafter. Different observations
have been recorded from post-HSCT survivors of se-
vere congenital immunodeficiency [32], in whom the
underlying genetic defect could have some negative in-
fluence on the neuropsychological outcome regardless
of the posttransplantation course.
We emphasize that in our univariate and multivar-
iate analyses, demographic factors, life aspect factors
(eg, school, work, leisure time, family relationships)
or emotional outcome factors (eg, body perception)
were not associated with a negative impact on LS in
either group. In particular, despite a relatively high
rate of post-HSCT late effects in our survivors, their
body image was very similar to that of controls, except
in 1 patient who had significant growth impairment,
a less severe complication in the other patients. One
possible explanation for this finding is that none of
the patients presented with signs and symptoms of
GVHD at the time of the study, and, importantly, no
increased body-related anxiety was reported. Sanders
et al. [23], in a large study ofQOL of adult survivors af-
ter childhood HSCT, found no correlation betweenprevious chronic GVHD and long-term physical dete-
rioration.
The high proportion of our patients reporting nor-
mal physical, psychosocial, and behavioral function
could be due to these patients’ increased capacity to
bear life’s difficulties, as has been described previously
[33,34]. Although stronger resilience acquired after
a chronic illness could represent a favorable factor
for LS after HSCT [35], we did not measure this in
the present study and so have no reliable data to sup-
port this concept.
Sutherland et al. [36] analyzed theLSofHSCTadult
subjects with an age-matched normal population and
found that survivors more than 3 years post-HSCT
had similar or, in some domains, even higher LS com-
pared with the normal population. Bieri et al. [30] and
Bishop et al. [37] recently evaluated the health and
screening patterns of HSCT survivors and found similar
health and screening behaviors as matched controls.
In terms of sexuality, our findings demonstrate
a sufficiently normal pattern inHSCT survivors, prob-
ably related to either normal hormone production or
replacement therapy. However, the information that
the vast majority of HSCT survivors are bound to be
infertile [6] has been identified as a burning issue;
thus, we have encouraged specific social and psycho-
logical support in some cases. In this regard, a comfort-
ing message concerning paternity seems to emerge
from recent data [38], where patients under age 25
years at the time of HSCT experiencing some reap-
pearance of spermatogenesis years after HSCT, even
when conditioned with standard TBI. Finally, we
note that there was no difference in marital status be-
tween the HSCT survivors and controls.
In conclusion, our research indicates that even if sur-
vivors of childhood HSCT experience of some physical
discomfort, they are not necessarily at risk for future
low level of LS or behavioral disturbances. As a final
comment, althoughmost of our cured adolescents could
be considered so-called ‘‘fortunate survivors,’’ we point
out that continuous long-term follow-up is of great im-
portance to detect negative physical or psychological ef-
fects whenever these findings emerge. Therefore, we
suggest a long-term evaluation of LS in bothmulticenter
and single-center studies that does not exclude a simple
methodology such as we have adopted here. The selec-
tionofpopulationnorms remains oneof themost impor-
tant barriers to measuring LS or QOL after HSCT, and
future studies should use more appropriate measures to
compare control groups and cancer survivors. Programs
including medical, teaching, and psychosocial support
mustbeencouraged, alongwith screeningandpreventive
practices recently recommendedby theEuropeanGroup
for Blood and Marrow Transplantation, Center for In-
ternational Blood and Marrow Transplant Research,
and American Society of Blood andMarrow Transplan-
tation consensus panel [39].
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